Abiopharma

Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Progyny, Inc. Announces Third Quarter 2025 Results

Assemblée Générale Mixte du 27 novembre 2025 - Modalités de mise à disposition des documents préparatoires

Information relative au nombre total de droits de vote et d’actions composant le capital social au 20 octobre 2025

Statement of total voting rights and shares forming the company’s share capital as October 20, 2025

Combined General Meeting of November 27, 2025 - Availability of the preparatory documents

IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates